Mano Y, Takayanagi T, et al
BPC-157 for Stomach Ulcers & Gastritis Studies show BPC-157 can: Heal and prevent gastric ulcers caused by NSAIDs, alcohol, and acid injury Boost blood flow to damaged tissues Protect stomach lining cells from oxidative stress Accelerate regeneration of mucosal layers These properties make it a promising adjunct for those struggling with recurrent ulcer pain and inflammation
Next steps: FDA decision (REDEFINE-1 & 2) expected late 2026 REDEFINE-11 (2.4/2.4 mg) readout in H1 2027 Higher-dose Phase 3 initiation planned H2 2026 Why It Matters: The obesity market is now a high-efficacy battleground, with GLP-1 and dual incretin therapies redefining standards of care
I kind of describe it as being in hibernation, right
Adems, su origen vegano lo hace adecuado para un amplio rango de usuarios
Solarski M, Wang H, Wille H, Schmitt-Ulms G (2018) Somatostatin in Alzheimers disease: a new role for an old player